mourning THE LOSS OF someone while they are still alive
Many of us know someone with Alzheimer’s disease, the most common form of dementia. Over $30 billion has been spent to develop a drug-based cure for it. So far, nothing works.
We are determined to end Alzheimer's disease with Arethusta®, a first-in-class outpatient treatment. Our first mission is to test it by reversing mild cognitive impairment associated with Alzheimer’s disease. Afterward, we intend to use Arethusta to prevent and cure Alzheimer’s itself. Our work is attracting significant attention.
The science
The facts
The team
HELP US FIGHT ALZHEIMER’S DISEASE
There is still time to enroll in our 2,000-person clinical study to assess risk of Alzheimer’s disease.
Recruitment ad for an Alzheimer's disease study in Riverside, CA. We're recruiting 2000 participants for a non-invasive observational study of Alzheimer's disease. Subjects are needed between 20 and 90 years of age, including healthy subjects and those with Alzheimer's disease, Frontotemporal dementia, Down syndrome, idiopathic dementia, and mild cognitive impairment.